Immunohistochemistry bore out the first hypothesis, showing that in an experimental model of radiation necrosis, mice did not develop elevated PARP1 expression as compared to contralateral or treatment-naïve brain, while glioblastoma xenografts expressed high levels of PARP1 in tumor cell nuclei (Fig. 2). The gene discussed is PARP1; the disease is neoplasm.